NCT01342770: Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer |
|
|
| Terminated | 2 | 6 | US | Laboratory Biomarker Analysis, Pioglitazone Hydrochloride, Actos, Pioglitazone.HCl, Quality-of-Life Assessment, Quality of Life Assessment | National Cancer Institute (NCI) | Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma, Stage IIB Non-Small Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung Cancer | 12/12 | 02/13 | | |